Product Images Alendronate Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Alendronate Sodium NDC 50090-2322 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - alendronate fig1

Figure 1 - alendronate fig1

The text describes the cumulative incidence of hip fractures in a three-year study conducted on patients with radiographic vertebral fracture at baseline. The percentage of cumulative incidence is shown through a graph that compares the placebo group to the group administered with Alendronate Sodium. The time frame of the study is measured in months.*

Figure 2 - alendronate fig2

Figure 2 - alendronate fig2

This text provides information about the increase in bone mineral density (BMD) in postmenopausal women who were administered Alendronate 10 mg/day for three years to treat osteoporosis. The BMD readings at different regions of the body, such as lumbar spine, femoral neck, and trochanter, are provided along with the percentage increase in BMD relative to a placebo. However, it is not clear what the "V72 vss" signifies, and that part of the text may be incomplete or inaccurate.*

Figure 3 - alendronate fig3

Figure 3 - alendronate fig3

Figure 4 - alendronate fig4

Figure 4 - alendronate fig4

Figure 5 - alendronate fig5

Figure 5 - alendronate fig5

Figure 6 - alendronate fig6

Figure 6 - alendronate fig6

The text describes a study on the effects of Alendronate 40mg/day on serum alkaline phosphatase in patients with Paget's Disease of Bone, compared to placebo or Etidronate 400mg/day. The study involved two groups, one with 27 patients from a multinational study, and the other with 41 patients from a US study. The data is presented as mean % change from baseline over a period of 6 months.*

Chemical Structure - alendronate str

Chemical Structure - alendronate str

Label Image - lbl500902322

Label Image - lbl500902322

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.